• PFHxS Disrupts Lipid Homeostasis via PPARα

  2026-08-19

  A 2024 Environmental Science & Technology study integrated zebrafish lipidomics, transcriptomics, computational modeling, and antagonist coexposure to examine PFHxS toxicity at environmentally relevant concentrations. The findings identify PPARα activation as a plausible molecular initiating event linking PFHxS exposure with broad lipid remodeling, while also illustrating how integrated omics can strengthen mechanistic inference in aquatic toxicology.

• Full-Length αvβ3 Integrin Conformations by Cryo-EM

  2026-08-19

  This cryo-EM study resolves a broad conformational landscape of full-length human αvβ3 integrin, including previously uncharacterized apo intermediates and distinct ligand-bound states. The findings clarify how integrin activation and inhibitor recognition may be structurally diverse, while providing practical guidance for analyzing intact membrane receptors.

• Cannabidiol, Orofacial Pain, and Affective Recovery

  2026-08-18

  A 2026 Brain Research Bulletin study shows that cannabidiol (CBD) can reduce acute orofacial inflammatory pain while also improving pain-associated affective and cognitive deficits in mice. By combining behavioral assays, molecular profiling, and fiber photometry, the study connects peripheral FAAH–endocannabinoid mechanisms with central CB1 signaling and serotonin dynamics.

• Human iPSC Sensory Neurons Model HSV-1 Latency

  2026-08-18

  Oh et al. establish a scalable human iPSC-derived sensory neuron system that supports experimentally defined HSV-1 latency and stimulus-induced reactivation. The model combines neuronal functional validation with virological, transcriptional, and chromatin-based criteria, providing a human-relevant platform for studying latency mechanisms and testing interventions.

• HPF for hROS Detection in Cell Assays

  2026-08-17

  HPF converts selective hROS chemistry into a practical green-fluorescence readout for live-cell microscopy, plate assays, and flow cytometry. This workflow shows how hydroxyphenyl fluorescein can dissect copper-mediated nanotherapy while avoiding the common mistake of treating one ROS signal as proof of an entire cell-death mechanism.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO)

  2026-08-17

  Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) helps limit proteolytic degradation during protein extraction and protease-sensitive assays. Its EDTA-free formulation is suitable for workflows sensitive to divalent cations, but it should not replace EDTA or phosphatase inhibitors when those reagents are specifically required.

• Vincristine Sulfate: Mechanism and Research Use

  2026-08-16

  Vincristine sulfate is a vincristine-containing alkaloid that disrupts microtubule dynamics by inhibiting tubulin polymerization. Its documented activity in cancer research includes B16 melanoma assays and rhabdomyosarcoma xenografts, while product-specific solubility and storage information supports reproducible experimental planning.

• Electrostatic Partitioning in α-Synuclein Condensates

  2026-08-15

  The reference study shows that α-synuclein condensates have a strongly negative electrostatic potential that controls how labeled proteins, fluorophores, and small molecules partition into them. By combining charge-tuned probes, zeta-potential measurements, and a differentiated SH-SY5Y cell model, the work provides a practical framework for studying condensate organization in vitro and inside cells.

• Pravastatin sodium: Assay Workflows

  2026-08-14

  Pravastatin sodium is a selective HMG-CoA reductase inhibitor for probing cholesterol biosynthesis, macrophage lipid handling, and LDL-related phenotypes. This guide translates its biochemical potency into practical cell-based workflows while adding transporter-aware controls for hepatocyte and botanical-interaction studies.

• WRN–MMR Synthetic Lethality in Colon Cancer

  2026-08-14

  The reference study identifies a p53/PUMA-mediated apoptotic mechanism underlying the selective dependence of microsatellite instability colorectal cancer cells on Werner helicase. Its genetic, isogenic, and xenograft experiments support WRN as a therapeutic vulnerability in p53-wild-type MSI tumors while clarifying important limits for pharmacological translation.

• Immune Rejuvenation in Alzheimer’s Disease Mice

  2026-08-13

  Sun and colleagues tested whether replacing aged hematopoietic immune cells with young bone marrow could reduce Alzheimer’s disease-like pathology in aged APP/PS1 mice. Young bone marrow transplantation reshaped peripheral immune-cell gene expression, reduced inflammatory and senescence-associated signals, enhanced peripheral monocyte-associated Aβ clearance, and improved pathological and behavioral outcomes.

• Baicalin: From Cortical Plasticity to Assay Design

  2026-08-13

  Baicalin reactivated adult visual-cortex plasticity in an amblyopia model through inhibition-sensitive mechanisms. This article translates that finding into assay design, formulation controls, and a carefully bounded framework for cancer research applications.

• ROCK Signaling at the iPSC–Translation Interface

  2026-08-12

  Y-27632 dihydrochloride is more than a routine ROCK inhibitor: it can serve as a mechanistic probe and workflow-control reagent across iPSC, organoid, cytoskeletal, and cancer research. This article connects ROCK biology with translational strategy, using schizophrenia-relevant iPSC lines as a model for designing more rigorous viability, differentiation, and disease-modeling experiments.

• Topotecan Workflows for Chemoresistance Studies

  2026-08-12

  Topotecan, also known as SKF104864, supports reproducible studies of topoisomerase I inhibition, apoptosis, cell-cycle effects, and transporter-mediated drug resistance. This workflow-centered guide connects dose-response assays with intracellular accumulation measurements, glioma models, and ABCG2-focused chemosensitization experiments.

• ICAA Targets RIP3 in Cardiac Hypertrophy

  2026-08-11

  This study identifies isochlorogenic acid A (ICAA) as a direct regulator of RIP3 and shows that it attenuates angiotensin II- and pressure overload-induced cardiac hypertrophy through the RIP3/CaMKII axis. The work separates RIP3-dependent hypertrophic signaling from canonical MLKL-mediated necroptosis, providing a mechanistic basis for further cardiovascular disease research.

16677 records 1/1112 page Next 12345 下5页 Last page